You conveniently left out the fact that the investment is to be in staged tranches.
For all we know the initial tranche for early stage research could be as little as $1m with the balance to potentially tipped in over 15 years of development.
All I know is Starpharma have chosen to give away their IP in exchange for a minority equity stake in a new non-listed entity controlled by others, rather than demanding a cash up front licence fee.
That’s a fact.
Outmanoeuvred IMO.
You conveniently left out the fact that the investment is to be...
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.11M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14171 | 9.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.1¢ | 1908 | 1 |
View Market Depth
| Last trade - 08.50am 15/08/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable